SMC4 expression based on
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison | Statistical significance |
Normal-vs-Primary | 3.34249961042588E-10 |
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
2.26529999999281E-05 |
Normal-vs-Stage2 |
1.562450E-03 |
Normal-vs-Stage3 |
N/A |
Normal-vs-Stage4 |
2.320600E-03 |
Stage1-vs-Stage2 |
5.985200E-01 |
Stage1-vs-Stage3 |
N/A |
Stage1-vs-Stage4 |
7.255600E-01 |
Stage2-vs-Stage3 |
N/A |
Stage2-vs-Stage4 |
8.726600E-01 |
Stage3-vs-Stage4 |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
9.53849998985845E-09 |
Normal-vs-AfricanAmerican |
1.991750E-01 |
Normal-vs-Asian |
9.535900E-02 |
Caucasian-vs-AfricanAmerican |
5.341400E-01 |
Caucasian-vs-Asian |
3.349800E-01 |
AfricanAmerican-vs-Asian |
3.155400E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.4310000000517E-06 |
Normal-vs-Female |
3.57220000000158E-05 |
Male-vs-Female |
8.888800E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient BMI information is not available for 1 sample.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
2.676100E-03 |
Normal-vs-Extreme_Weight |
2.963500E-04 |
Normal-vs-Obese |
9.589800E-04 |
Normal-vs-Extreme_Obese |
N/A |
Normal_Weight-vs-Extreme_Weight |
9.826200E-01 |
Normal_Weight-vs-Obese |
5.954800E-01 |
Normal_Weight-vs-Extreme_Obese |
N/A |
Extreme_Weight-vs-Obese |
6.309600E-01 |
Extreme_Weight-vs-Extreme_Obese |
N/A |
Obese-vs-Extreme_Obese |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
2.161800E-01 |
Normal-vs-Age(41-60Yrs) |
1.003850E-04 |
Normal-vs-Age(61-80Yrs) |
4.46350000000706E-05 |
Normal-vs-Age(81-100Yrs) |
1.52650003748533E-09 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.993200E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.189600E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.758200E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.929000E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.690000E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.408000E-01 |
|
|
CHOL : Cholangiocarcinoma
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
N/A |
Normal-vs-Grade 2 |
4.734000E-01 |
Normal-vs-Grade 3 |
5.888200E-01 |
Normal-vs-Grade 4 |
1.000000E+00 |
Grade 1-vs-Grade 2 |
N/A |
Grade 1-vs-Grade 3 |
N/A |
Grade 1-vs-Grade 4 |
N/A |
Grade 2-vs-Grade 3 |
2.069700E-02 |
Grade 2-vs-Grade 4 |
4.734000E-01 |
Grade 3-vs-Grade 4 |
5.888200E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 5 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
4.62579999971346E-07 |
Normal-vs-N1 |
6.323400E-03 |
N0-vs-N1 |
7.419200E-01 |
|
|